Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Neural Crest Differentiation WP2064,0.0005175598855284534,35.34591194968554,267.4407892518793,"['DLX5', 'LHX2', 'FGFR2', 'GFAP']",0.06314230603447132,0,0,4
2,Ectoderm Differentiation WP2858,0.0018620222763179525,8.867088607594937,55.73933597027634,"['PIM1', 'ROR2', 'NR2F2', 'JAKMIP1', 'FGFR2']",0.11358335885539511,0,0,5
3,Hematopoietic Stem Cell Differentiation WP2849,0.010733203388809686,inf,inf,"['PIM1', 'RUNX1']",0.43648360447826057,0,0,2
4,Fragile X Syndrome  WP4549,0.041630541814688254,5.25375,16.701257269495382,"['CDKN2A', 'PPP2R5B', 'SHANK1']",0.6441881136455992,0,0,3
5,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.05591531827336065,8.720496894409937,25.149188426220174,"['IGFBP5', 'PLD1']",0.6441881136455992,0,0,2
6,Prader-Willi and Angelman Syndrome WP3998,0.05591531827336065,8.720496894409937,25.149188426220174,"['DLX5', 'CDKN2A']",0.6441881136455992,0,0,2
7,Ras signaling WP4223,0.05778654203137864,4.375,12.473122231683169,"['PLD1', 'FGFR2', 'ARF6']",0.6441881136455992,0,0,3
8,Peptide GPCRs WP24,0.08692135483047694,5.809523809523809,14.191223212735,"['MC1R', 'ACKR1']",0.6441881136455992,0,0,2
9,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.10388757262886365,inf,inf,['APOE'],0.6441881136455992,0,0,1
10,Intraflagellar transport proteins binding to dynein WP4532,0.10388757262886365,inf,inf,['WDR34'],0.6441881136455992,0,0,1
11,Vitamin D in inflammatory diseases WP4482,0.10388757262886365,inf,inf,['DUSP1'],0.6441881136455992,0,0,1
12,Wnt Signaling Pathway WP363,0.10388757262886365,inf,inf,['ROR2'],0.6441881136455992,0,0,1
13,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.10388757262886365,inf,inf,['RPH3AL'],0.6441881136455992,0,0,1
14,NAD+ metabolism WP3644,0.10388757262886365,inf,inf,['NMNAT1'],0.6441881136455992,0,0,1
15,Disruption of postsynaptic signaling by CNV WP4875,0.10388757262886365,inf,inf,['SHANK1'],0.6441881136455992,0,0,1
16,Head and Neck Squamous Cell Carcinoma WP4674,0.1216891693235652,4.354037267080745,9.170844594754202,"['CDKN2A', 'FGFR2']",0.6441881136455992,0,0,2
17,22q11.2 copy number variation syndrome WP4657,0.15911296196339103,3.480745341614907,6.3981002928097706,"['DGCR6L', 'FGFR2']",0.6441881136455992,0,0,2
18,MECP2 and Associated Rett Syndrome WP3584,0.15911296196339103,3.480745341614907,6.3981002928097706,"['DLX5', 'SGK1']",0.6441881136455992,0,0,2
19,Pancreatic adenocarcinoma pathway WP4263,0.15911296196339103,3.480745341614907,6.3981002928097706,"['CDKN2A', 'PLD1']",0.6441881136455992,0,0,2
20,Hippo-Merlin Signaling Dysregulation WP4541,0.15911296196339103,3.480745341614907,6.3981002928097706,"['PPP1R14A', 'FGFR2']",0.6441881136455992,0,0,2
21,Splicing factor NOVA regulated synaptic proteins WP4148,0.1970419885913697,8.67283950617284,14.087626532228748,['NTNG1'],0.6441881136455992,0,0,1
22,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.1970419885913697,8.67283950617284,14.087626532228748,['LCP2'],0.6441881136455992,0,0,1
23,Mammalian disorder of sexual development WP4842,0.1970419885913697,8.67283950617284,14.087626532228748,['FGFR2'],0.6441881136455992,0,0,1
24,Transcription co-factors SKI and SKIL protein partners WP4533,0.1970419885913697,8.67283950617284,14.087626532228748,['MERTK'],0.6441881136455992,0,0,1
25,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.1970419885913697,8.67283950617284,14.087626532228748,['APOE'],0.6441881136455992,0,0,1
26,Tryptophan catabolism leading to NAD+ production WP4210,0.1970419885913697,8.67283950617284,14.087626532228748,['NMNAT1'],0.6441881136455992,0,0,1
27,Composition of Lipid Particles WP3601,0.1970419885913697,8.67283950617284,14.087626532228748,['APOE'],0.6441881136455992,0,0,1
28,NAD Biosynthesis II (from tryptophan) WP2485,0.1970419885913697,8.67283950617284,14.087626532228748,['NMNAT1'],0.6441881136455992,0,0,1
29,NAD+ biosynthetic pathways WP3645,0.1970419885913697,8.67283950617284,14.087626532228748,['NMNAT1'],0.6441881136455992,0,0,1
30,Dual hijack model of Vif in HIV infection WP3300,0.1970419885913697,8.67283950617284,14.087626532228748,['RUNX1'],0.6441881136455992,0,0,1
31,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.1970419885913697,8.67283950617284,14.087626532228748,['FGFR2'],0.6441881136455992,0,0,1
32,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.1970419885913697,8.67283950617284,14.087626532228748,['SGK1'],0.6441881136455992,0,0,1
33,Glycerolipids and Glycerophospholipids WP4722,0.1970419885913697,8.67283950617284,14.087626532228748,['PLD1'],0.6441881136455992,0,0,1
34,T-cell receptor (TCR) signaling pathway WP69,0.1982737816409708,2.898550724637681,4.690163674856891,"['RIPK2', 'LCP2']",0.6441881136455992,0,0,2
35,PI3K-Akt signaling pathway WP4172,0.21050183496445674,1.8364779874213837,2.861711857536156,"['EFNA3', 'PPP2R5B', 'SGK1', 'FGFR2']",0.6441881136455992,0,0,4
36,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.23841299941631522,2.482697426796806,3.559569465335958,"['RIPK2', 'APOE']",0.6441881136455992,0,0,2
37,Cell cycle WP179,0.23841299941631522,2.482697426796806,3.559569465335958,"['CDKN2A', 'CDC14B']",0.6441881136455992,0,0,2
38,Glioblastoma signaling pathways WP2261,0.23841299941631522,2.482697426796806,3.559569465335958,"['CDKN2A', 'FGFR2']",0.6441881136455992,0,0,2
39,IL-4 signaling pathway WP395,0.2805659118563442,4.333333333333333,5.5074352742188815,['NFIL3'],0.6441881136455992,0,0,1
40,Airway smooth muscle cell contraction WP4962,0.2805659118563442,4.333333333333333,5.5074352742188815,['PPP1R14A'],0.6441881136455992,0,0,1
41,Angiogenesis WP1539,0.2805659118563442,4.333333333333333,5.5074352742188815,['FGFR2'],0.6441881136455992,0,0,1
42,BMP Signaling Pathway in Eyelid Development WP3927,0.2805659118563442,4.333333333333333,5.5074352742188815,['FGFR2'],0.6441881136455992,0,0,1
43,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.2805659118563442,4.333333333333333,5.5074352742188815,['FGFR2'],0.6441881136455992,0,0,1
44,Melatonin metabolism and effects WP3298,0.2805659118563442,4.333333333333333,5.5074352742188815,['APOE'],0.6441881136455992,0,0,1
45,Cell migration and invasion through p75NTR WP4561,0.2805659118563442,4.333333333333333,5.5074352742188815,['EFNA3'],0.6441881136455992,0,0,1
46,Type 2 papillary renal cell carcinoma WP4241,0.2805659118563442,4.333333333333333,5.5074352742188815,['COL21A1'],0.6441881136455992,0,0,1
47,Vitamin B12 metabolism WP1533,0.2805659118563442,4.333333333333333,5.5074352742188815,['APOE'],0.6441881136455992,0,0,1
48,Development and heterogeneity of the ILC family WP3893,0.2805659118563442,4.333333333333333,5.5074352742188815,['NFIL3'],0.6441881136455992,0,0,1
49,Nuclear receptors WP170,0.2805659118563442,4.333333333333333,5.5074352742188815,['NR2F2'],0.6441881136455992,0,0,1
50,Genes related to primary cilium development (based on CRISPR) WP4536,0.2805659118563442,4.333333333333333,5.5074352742188815,['WDR34'],0.6441881136455992,0,0,1
51,Glycogen Synthesis and Degradation WP500,0.2805659118563442,4.333333333333333,5.5074352742188815,['PPP2R5B'],0.6441881136455992,0,0,1
52,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.2805659118563442,4.333333333333333,5.5074352742188815,['FGFR2'],0.6441881136455992,0,0,1
53,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.2805659118563442,4.333333333333333,5.5074352742188815,['IFITM3'],0.6441881136455992,0,0,1
54,Spinal Cord Injury WP2431,0.319258261729285,1.9282263630089718,2.201561909549878,"['AQP4', 'GFAP']",0.6441881136455992,0,0,2
55,EGF/EGFR signaling pathway WP437,0.319258261729285,1.9282263630089718,2.201561909549878,"['PLD1', 'ARF6']",0.6441881136455992,0,0,2
56,VEGFA-VEGFR2 Signaling Pathway WP3888,0.34202937220643675,1.305095541401274,1.4001830562813464,"['DNAJA1', 'RCN1', 'DNAJB4', 'DNAJB9', 'PTPN9', 'ARF6']",0.6441881136455992,0,0,6
57,3q29 copy number variation syndrome WP4906,0.3554494322016773,2.8868312757201644,2.986058260232411,['WDR34'],0.6441881136455992,0,0,1
58,Male infertility WP4673,0.3554494322016773,2.8868312757201644,2.986058260232411,['TEX15'],0.6441881136455992,0,0,1
59,Bladder cancer WP2828,0.3554494322016773,2.8868312757201644,2.986058260232411,['CDKN2A'],0.6441881136455992,0,0,1
60,Cardiac Hypertrophic Response WP2795,0.3554494322016773,2.8868312757201644,2.986058260232411,['FGFR2'],0.6441881136455992,0,0,1
61,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.3554494322016773,2.8868312757201644,2.986058260232411,['PIM1'],0.6441881136455992,0,0,1
62,Tumor suppressor activity of SMARCB1 WP4204,0.3554494322016773,2.8868312757201644,2.986058260232411,['CDKN2A'],0.6441881136455992,0,0,1
63,White fat cell differentiation WP4149,0.3554494322016773,2.8868312757201644,2.986058260232411,['NR2F2'],0.6441881136455992,0,0,1
64,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.3554494322016773,2.8868312757201644,2.986058260232411,['RIPK2'],0.6441881136455992,0,0,1
65,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.3554494322016773,2.8868312757201644,2.986058260232411,['CDKN2A'],0.6441881136455992,0,0,1
66,Genes controlling nephrogenesis WP4823,0.3554494322016773,2.8868312757201644,2.986058260232411,['FGFR2'],0.6441881136455992,0,0,1
67,Glycosylation and related congenital defects WP4521,0.3554494322016773,2.8868312757201644,2.986058260232411,['MAGT1'],0.6441881136455992,0,0,1
68,Integrated breast cancer pathway WP1984,0.3590556699008258,1.73416149068323,1.7762631740165404,"['DCAKD', 'JAKMIP1']",0.6441881136455992,0,0,2
69,Alzheimer's disease WP2059,0.4225814301726359,2.1635802469135803,1.8636498603399698,['APOE'],0.6525941073552098,0,0,1
70,Statin inhibition of cholesterol production WP430,0.4225814301726359,2.1635802469135803,1.8636498603399698,['APOE'],0.6525941073552098,0,0,1
71,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.4225814301726359,2.1635802469135803,1.8636498603399698,['DCN'],0.6525941073552098,0,0,1
72,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4225814301726359,2.1635802469135803,1.8636498603399698,['PLD1'],0.6525941073552098,0,0,1
73,TP53 network WP1742,0.4225814301726359,2.1635802469135803,1.8636498603399698,['CDKN2A'],0.6525941073552098,0,0,1
74,Complement system WP2806,0.4225814301726359,2.1635802469135803,1.8636498603399698,['DCN'],0.6525941073552098,0,0,1
75,Zinc homeostasis WP3529,0.4225814301726359,2.1635802469135803,1.8636498603399698,['SLC39A11'],0.6525941073552098,0,0,1
76,DNA IR-double strand breaks and cellular response via ATM WP3959,0.4225814301726359,2.1635802469135803,1.8636498603399698,['CDKN2A'],0.6525941073552098,0,0,1
77,Fas ligand pathway and stress induction of heat shock proteins WP314,0.4225814301726359,2.1635802469135803,1.8636498603399698,['RIPK2'],0.6525941073552098,0,0,1
78,G1 to S cell cycle control WP45,0.4225814301726359,2.1635802469135803,1.8636498603399698,['CDKN2A'],0.6525941073552098,0,0,1
79,Rett syndrome causing genes WP4312,0.4225814301726359,2.1635802469135803,1.8636498603399698,['KCNJ10'],0.6525941073552098,0,0,1
80,Insulin Signaling WP481,0.43578823858419224,1.443064182194617,1.1986074429051303,"['SGK1', 'ARF6']",0.6563724087317464,0,0,2
81,Vitamin D Receptor Pathway WP2877,0.43578823858419224,1.443064182194617,1.1986074429051303,"['IGFBP5', 'CDKN2A']",0.6563724087317464,0,0,2
82,MAPK Signaling Pathway WP382,0.47228748732068193,1.3311036789297659,0.9985505799712027,"['DUSP1', 'FGFR2']",0.6617606999423066,0,0,2
83,Imatinib and Chronic Myeloid Leukemia WP3640,0.48275985487594497,1.7296296296296296,1.2595784658368914,['PIM1'],0.6617606999423066,0,0,1
84,Melanoma WP4685,0.48275985487594497,1.7296296296296296,1.2595784658368914,['CDKN2A'],0.6617606999423066,0,0,1
85,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.48275985487594497,1.7296296296296296,1.2595784658368914,['FGFR2'],0.6617606999423066,0,0,1
86,One-carbon metabolism and related pathways WP3940,0.48275985487594497,1.7296296296296296,1.2595784658368914,['PLD1'],0.6617606999423066,0,0,1
87,Eukaryotic Transcription Initiation WP405,0.48275985487594497,1.7296296296296296,1.2595784658368914,['GTF2A2'],0.6617606999423066,0,0,1
88,Photodynamic therapy-induced unfolded protein response WP3613,0.48275985487594497,1.7296296296296296,1.2595784658368914,['DNAJB9'],0.6617606999423066,0,0,1
89,"GPCRs, Other WP117",0.48275985487594497,1.7296296296296296,1.2595784658368914,['ACKR1'],0.6617606999423066,0,0,1
90,7q11.23 copy number variation syndrome WP4932,0.5367009726072187,1.440329218106996,0.8963373072456319,['GTF2IRD1'],0.6670637107052197,0,0,1
91,Apoptosis WP254,0.5367009726072187,1.440329218106996,0.8963373072456319,['CDKN2A'],0.6670637107052197,0,0,1
92,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.5367009726072187,1.440329218106996,0.8963373072456319,['ROR2'],0.6670637107052197,0,0,1
93,Wnt signaling WP428,0.5367009726072187,1.440329218106996,0.8963373072456319,['ROR2'],0.6670637107052197,0,0,1
94,Monoamine GPCRs WP58,0.5367009726072187,1.440329218106996,0.8963373072456319,['HTR5A'],0.6670637107052197,0,0,1
95,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.5367009726072187,1.440329218106996,0.8963373072456319,['ROR2'],0.6670637107052197,0,0,1
96,Non-small cell lung cancer WP4255,0.5367009726072187,1.440329218106996,0.8963373072456319,['CDKN2A'],0.6670637107052197,0,0,1
97,Endometrial cancer WP4155,0.5367009726072187,1.440329218106996,0.8963373072456319,['FGFR2'],0.6670637107052197,0,0,1
98,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.5367009726072187,1.440329218106996,0.8963373072456319,['PPP1R14A'],0.6670637107052197,0,0,1
99,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.5438011488463242,1.0796875,0.6577149987565167,"['EFNA3', 'PPP2R5B', 'FGFR2']",0.6670637107052197,0,0,3
100,Senescence and Autophagy in Cancer WP615,0.5727735827798759,1.079192546583851,0.6013960012021811,"['IGFBP5', 'CDKN2A']",0.6670637107052197,0,0,2
101,"GPCRs, Class A Rhodopsin-like WP455",0.5727735827798759,1.079192546583851,0.6013960012021811,"['MC1R', 'HTR5A']",0.6670637107052197,0,0,2
102,Cardiac Progenitor Differentiation WP2406,0.5850476807004796,1.2336860670194003,0.6613321336079991,['ROR2'],0.6670637107052197,0,0,1
103,Modulators of TCR signaling and T cell activation WP5072,0.5850476807004796,1.2336860670194003,0.6613321336079991,['LCP2'],0.6670637107052197,0,0,1
104,Development of ureteric collection system WP5053,0.5850476807004796,1.2336860670194003,0.6613321336079991,['FGFR2'],0.6670637107052197,0,0,1
105,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5850476807004796,1.2336860670194003,0.6613321336079991,['FGFR2'],0.6670637107052197,0,0,1
106,Exercise-induced Circadian Regulation WP410,0.5850476807004796,1.2336860670194003,0.6613321336079991,['DNAJA1'],0.6670637107052197,0,0,1
107,Pathways Regulating Hippo Signaling WP4540,0.5850476807004796,1.2336860670194003,0.6613321336079991,['FGFR2'],0.6670637107052197,0,0,1
108,Ciliary landscape WP4352,0.66720669479968,0.958161865569273,0.38772536705117727,['WDR34'],0.7140282172417628,0,0,1
109,Ciliopathies WP4803,0.66720669479968,0.958161865569273,0.38772536705117727,['WDR34'],0.7140282172417628,0,0,1
110,DNA damage response (only ATM dependent) WP710,0.66720669479968,0.958161865569273,0.38772536705117727,['CDKN2A'],0.7140282172417628,0,0,1
111,Ebola Virus Pathway on Host WP4217,0.66720669479968,0.958161865569273,0.38772536705117727,['MERTK'],0.7140282172417628,0,0,1
112,ESC Pluripotency Pathways WP3931,0.66720669479968,0.958161865569273,0.38772536705117727,['FGFR2'],0.7140282172417628,0,0,1
113,Osteoblast differentiation WP4787,0.66720669479968,0.958161865569273,0.38772536705117727,['FGFR2'],0.7140282172417628,0,0,1
114,Gastrin signaling pathway WP4659,0.66720669479968,0.958161865569273,0.38772536705117727,['CDKN2A'],0.7140282172417628,0,0,1
115,Regulation of Actin Cytoskeleton WP51,0.7020015009168332,0.8617283950617284,0.30489651402038315,['FGFR2'],0.7447320270595971,0,0,1
116,Apoptosis Modulation and Signaling WP1772,0.7331783567602971,0.7828282828282829,0.2429635038426512,['CDKN2A'],0.7645107651688569,0,0,1
117,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.7331783567602971,0.7828282828282829,0.2429635038426512,['AQP4'],0.7645107651688569,0,0,1
118,Circadian rhythm related genes WP3594,0.7611113727238663,0.7170781893004116,0.19574483558861894,['NFIL3'],0.7869117582399295,0,0,1
119,Myometrial relaxation and contraction pathways WP289,0.8085539156953414,0.6137566137566137,0.13042813898741903,['IGFBP5'],0.8289376278557281,0,0,1
120,IL-18 signaling pathway WP4754,0.8214535716292356,0.6344605475040258,0.1247856114570437,"['PLD1', 'ARF6']",0.8351444644897228,0,0,2
121,NRF2 pathway WP2884,0.8627292918290016,0.5043572984749455,0.07447053384675024,['SLC39A11'],0.8698592859763487,0,0,1
122,Nuclear Receptors Meta-Pathway WP2882,0.9677798001953443,0.2831275720164609,0.009272625244154007,['SLC39A11'],0.9677798001953443,0,0,1
